Evonik would like to explore potential collaborations with startups working on new approaches and technologies that can help address innovation challenges in the specialty chemical industry. The selected startups will be invited to present to their executive team in-person on Thursday, June 29.
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Looking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.
Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio
Startup Lightning Talks - 2022 MIT Health Science Technologies Conference The Future of Cell & Gene Therapies
P&G is looking to partner with companies and emerging disruptors to address key shopper and retailer pain points in urban to deliver a breakthrough experience which disproportionately drives P&G brands.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
JC Gutiérrez-Ramos, President and CEO, Synlogic